Amit Hasija
CIK: 0001787700
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Milestone Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Feb 2, 2026MIST
Milestone Pharmaceuticals Inc.
Award(A)DirectEmployee Stock Option (right to buy)
204K shares- - Feb 2, 2026MIST
Milestone Pharmaceuticals Inc.
Award(A)DirectEmployee Stock Option (right to buy)
204K shares- - Feb 2, 2026MIST
Milestone Pharmaceuticals Inc.
Award(A)DirectRestricted Stock Unit
136K shares- - Jan 26, 2026MIST
Milestone Pharmaceuticals Inc.
Exercise(M)Direct20.1K shares- - Jan 26, 2026MIST
Milestone Pharmaceuticals Inc.
Sale(S)Direct12.2K shares at avg. $1.93$24K - Dec 15, 2025MIST
Milestone Pharmaceuticals Inc.
Sale(S)Direct58K shares at avg. $2.32$135K - Dec 12, 2025MIST
Milestone Pharmaceuticals Inc.
Award(A)Direct100K shares- - Jul 11, 2025MIST
Milestone Pharmaceuticals Inc.
Award(A)Direct50K shares- - Jan 27, 2025MIST
Milestone Pharmaceuticals Inc.
Award(A)DirectRestricted Stock Unit
80.4K shares- - Jan 27, 2025MIST
Milestone Pharmaceuticals Inc.
Award(A)DirectEmployee Stock Option (right to buy)
120.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc. | Award(A) Employee Stock Option (right to buy) | 204,000 | - | - | Direct |
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc. | Award(A) Employee Stock Option (right to buy) | 204,000 | - | - | Direct |
| Feb 2, 2026 | MIST Milestone Pharmaceuticals Inc. | Award(A) Restricted Stock Unit | 136,000 | - | - | Direct |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc. | Exercise(M) | 20,100 | - | $0 | Direct |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc. | Sale(S) | 12,245 | $1.93 | $23,633 | Direct |
| Dec 15, 2025 | MIST Milestone Pharmaceuticals Inc. | Sale(S) | 58,007 | $2.32 | $134,576 | Direct |
| Dec 12, 2025 | MIST Milestone Pharmaceuticals Inc. | Award(A) | 100,000 | - | $0 | Direct |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | Award(A) | 50,000 | - | - | Direct |
| Jan 27, 2025 | MIST Milestone Pharmaceuticals Inc. | Award(A) Restricted Stock Unit | 80,400 | - | - | Direct |
| Jan 27, 2025 | MIST Milestone Pharmaceuticals Inc. | Award(A) Employee Stock Option (right to buy) | 120,600 | - | - | Direct |
1-10 of 10 transactions
About Hasija Amit
Hasija Amit (SEC CIK 0001787700) files insider reports with the SEC as CFO & EVP of Corp. Development of Milestone Pharmaceuticals Inc. (MIST).
Signal8 holds 5 ownership filings by Hasija Amit, all Form 4s, filed between Jan 29, 2025 and Feb 5, 2026. Those filings report 10 transactions, from Jan 27, 2025 to Feb 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hasija Amit's filings is in MONTREAL, A8.
Recent filings by Hasija Amit
- Feb 2, 2026: Grants or awards of MIST derivative securities (3 lines, Form 4, code A).
- Jan 26, 2026: Option exercise of MIST shares (Form 4, code M).
- Jan 26, 2026: Open-market sale of MIST shares (Form 4, code S).
- Dec 15, 2025: Open-market sale of MIST shares (Form 4, code S).
- Dec 12, 2025: Grant or award of MIST shares (Form 4, code A).
Other insiders filing for Milestone Pharmaceuticals Inc. (MIST)
- Giles Lisa M., Director
- Fischer Seth H. Z., Director
- Duty Stuart, Director
- Wills Robert James, Director
- TOMSICEK MICHAEL JOHN, Director
- Saik Andrew, Director